The global proteomics market is projected to grow nearly six-fold to $5.6 billion by 2006, according to market research conducted by Frost & Sullivan. In 2000, the total market was $963 million, the consultancy said.
In a report released in August, Frost & Sullivan said the discovery that the human genome contains fewer genes than originally predicted has elevated the potential importance of proteins and led to an interest in proteome-wide studies.
The report, which separates proteomics by tool providers and drug discovery companies, offers the most aggressive forecast to date for the sector.
In June, Front Line Strategic Management Consulting forecast that the proteomics market would increase from a $561-million market to a $2.8-billion market by 2005.
In its report, Front Line forecast that a few players would continue to control the mass spectrometry market and that the 2D gel market would shrink as faster, simpler tools were developed.
Front Line said that the protein chip market would also grow, naming Ciphergen Biosystems as a leader in the space. The report also singled out Integrative Proteomics for its efforts to speed up protein analysis. — Kirell Lakhman